Indeed, SHP099/TNO155 treatment did not significantly inhibit MC38 xenograft growth in immune-compromised NSG mice (Supplementary Fig. 10e,f), suggesting that SHP2 inhibition in immune cells contributed to decreasing the tumor load in MC38 syngeneic mouse model. The gene discussed is PTPN11; the disease is neoplasm.